GeminIQ Website Logo

Viewing EDSA free

Subscribe for full history, 90+ metrics, screener, watchlist...

Edesa Biotech, Inc.

EDSA

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
101012111214212345
Accounts And Other Receivables Net Current
000100001111
Assets Current
Assets Current
111013121314223456
Prepaid Expense And Other Assets Current
000000000000
Assets Noncurrent
Deposits Assets Noncurrent
000000000000
Property Plant And Equipment Net
-------00000
Finite Lived Intangible Assets Net
222222222222
Operating Lease Right Of Use Asset
---000000000
Assets
131215141516445689
Liabilities And Stockhold…
Operating Lease Liability Current
---000000000
Liabilities Current
Accounts Payable And Accrued Liabilities Current
421111222222
Liabilities Current
421111222222
Common Stock Value
625958555454484747474747
Preferred Stock Value
------1-----
Liabilities Noncurrent
Stockholders Equity
Operating Lease Liability Noncurrent
-------00000
Stockholders Equity
91014121416223467
Additional Paid In Capital
161615151414141413131313
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-0-0-0-0-0-0-0
Liabilities
-------22222
Long Term Loans Payable
-----------0
Retained Earnings Accumulated Deficit
-78-72-68-66-64-62-60-59-58-56-54-52
Capital Units
-----------47
Other Commitments
Liabilities And Stockholders Equity
131215141516445689
Common Stock No Par Value
000000000--0
Shares Outstanding
1098777333333
Preferred Stock Shares Issued
------0-----
Common Stock Shares Issued
1098777333333

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026539.22%501.96%1624.51%-62.63%-48.67%-64.07%------
2025-13.38%-14.13%-11.52%-9.85%2.46%5.42%9.43%17.45%29.25%-13.79%-32.76%26.44%
2024-0.41%-13.25%-8.49%-6.07%-7.16%17.57%-7.02%-11.36%-29.75%-3.09%-1.55%12.89%
2023----------14.26%-12.52%-7.32%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.76
4.76
16.82
10.67
18.97
15.73
1.09
0.91
1.29
1.97
2.73
3.53
Quick Ratio
2.70
4.67
16.51
10.60
18.80
15.61
1.01
0.71
1.10
1.82
2.52
3.29
Working Capital
6.87M
8.23M
11.96M
10.43M
12.09M
13.47M
171.71K
-157.21K
686.01K
2.09M
3.43M
4.61M
Leverage & Debt
Debt to Equity
0.44
0.21
0.05
0.09
0.05
0.06
0.84
0.93
0.82
0.50
0.34
0.26
Debt Ratio
0.31
0.18
0.05
0.08
0.05
0.06
0.46
0.48
0.45
0.33
0.25
0.21
Efficiency & Turnover
Asset Turnover TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Per Share Metrics
Free Cash Flow Per Share TTM
-0.99
-0.88
-0.99
-1.29
-0.94
-1.08
-1.49
-1.53
-1.67
-1.99
-2.00
-2.32
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Growth Metrics
Net Income Growth (1Y)
138.24%
78.89%
27.94%
16.46%
-14.57%
-19.42%
-20.85%
-26.32%
-26.82%
-45.40%
-50.22%
-52.28%
EPS Growth (1Y)
85.74%
11.13%
-46.32%
-34.40%
-60.80%
-51.51%
-25.99%
-34.12%
-33.44%
243.01%
207.98%
-60.27%
Valuation Metrics
P/E TTM
-5.19
-4.28
-1.45
-1.95
-2.41
-2.22
-0.92
-2.31
-1.99
-1.85
-1.85
-1.51
P/B TTM
8.31
4.38
0.81
1.13
1.01
0.83
2.48
7.18
4.81
3.09
2.45
1.79
Market Cap
73.23M
44.67M
11.32M
14.02M
14.26M
12.95M
5.62M
14.23M
13.79M
13.38M
14.30M
12.61M
Enterprise Value
62.90M
34.67M
-730.75K
3.23M
1.89M
-950.59K
4.06M
13.19M
11.75M
10.58M
10.03M
7.25M
Calculated Values
Free Cash Flow TTM
-8.91M
-7.53M
-7.89M
-7.32M
-6.57M
-5.72M
-5.00M
-4.89M
-5.39M
-6.34M
-6.25M
-6.64M
Net Debt
-10.33M
-10.00M
-12.05M
-10.79M
-12.36M
-13.90M
-1.56M
-1.04M
-2.04M
-2.80M
-4.27M
-5.36M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-03-10Purchase
Owner: Nijhawan, Pardeep
Title: Chief Executive Officer
Shares: 1,000
Price/Share: $6.60
Value: $6,600.00
Shares Owned: 628,813
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct
2026-03-05Purchase
Owner: Nijhawan, Pardeep
Title: Chief Executive Officer
Shares: 10,000
Price/Share: $3.90
Value: $39,000.00
Shares Owned: 402,702
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-03-04Purchase
Owner: Nijhawan, Pardeep
Title: Chief Executive Officer
Shares: 10,000
Price/Share: $4.26
Value: $42,600.00
Shares Owned: 392,702
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-03-03Purchase
Owner: Nijhawan, Pardeep
Title: Chief Executive Officer
Shares: 10,000
Price/Share: $3.63
Value: $36,300.00
Shares Owned: 382,702
Relationship: Director,Officer,TenPercentOwner
Ownership: Indirect
2026-03-02Purchase
Owner: Nijhawan, Pardeep
Title: Chief Executive Officer
Shares: 2,000
Price/Share: $2.00
Value: $4,000.00
Shares Owned: 627,813
Relationship: Director,Officer,TenPercentOwner
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
30.65%
Inst. Shares: 2,617,469
Shares Outstanding: 8,541,146
2025-12-31
38.29%
Inst. Shares: 3,052,670
Shares Outstanding: 7,972,532
2025-09-30
50.01%
Inst. Shares: 2,839,198
Shares Outstanding: 5,676,708
2025-06-30
29.52%
Inst. Shares: 2,073,148
Shares Outstanding: 7,022,678
2025-03-31
52.25%
Inst. Shares: 2,772,253
Shares Outstanding: 5,305,763

Edesa Biotech, Inc. (EDSA) — SEC Financial Statements & Analysis

Edesa Biotech, Inc. (EDSA) is a pharmaceutical preparations company, incorporated in A1. Edesa Biotech, Inc. trades on Nasdaq as: EDSA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Edesa Biotech, Inc. reported a Debt-to-Equity ratio of 0.44x, a Price-to-Book (P/B) ratio of 8.31x (TTM), at a market cap of $73.23M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity
0.44x
P/B TTM
8.31x
Market Cap
$73.23M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Edesa Biotech, Inc. in?

Edesa Biotech, Inc. (EDSA) operates in the Pharmaceutical Preparations industry.

What is EDSA's market cap?

Edesa Biotech, Inc. (EDSA) has a market capitalization of $73.23M as of 2026-06-30.

What exchange does EDSA trade on?

Edesa Biotech, Inc. (EDSA) trades on the Nasdaq.

Where is Edesa Biotech, Inc. incorporated?

Edesa Biotech, Inc. is incorporated in British Columbia, Canada.

Wall Street's data.
Main Street's price.